| Original language | English (US) |
|---|---|
| Pages (from-to) | e2-e3 |
| Journal | American journal of public health |
| Volume | 112 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 1 2022 |
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: American journal of public health, Vol. 112, No. 2, 01.02.2022, p. e2-e3.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Editorial Note
AU - Kapadia, Farzana
N1 - Funding Information: Joanna E. Cohen’s effort in preparing this letter was supported by her professorship fund. Suchitra Krishnan-Sarin’s effort was supported by National Institutes of Health (NIH) grant U54DA036151. Thomas Eissenberg’s research is supported by the National Institute on Drug Abuse and the Center for Tobacco Products of the US Food and Drug Administration (FDA; award U54DA036105). Thomas J. Gould is supported by funding from the NIH (grants DA041632 and DA048166). Micah L. Berman receives funding from the National Cancer Institute (grant K07CA197221) and the American Heart Association. Also, he has received contract research funding from the Truth Initiative and the World Health Organization. Aruni Bhatnagar’s research is supported by the National Heart, Lung, and Blood Institute (grant HL120163). Lucy Popova receives funding from the NIH and the FDA (grants R01DA047397 and R01CA239308). Andy S. L. Tan is supported by funding from the NIH (grants R01CA237670, R21DA052421, 1OT2HL161568, R01DA054236, and R01CA224545). Eric Soule’s effort is supported by grant R15ES032138 from the National Institute of Environment Health Sciences, grant R21CA239188 from the National Cancer Institute and the Center for Tobacco Products, and grant U54DA036105 from the National Institute on Drug Abuse and the FDA. Pamela M. Ling receives funding from the National Cancer Institute (grants R01-CA87472 and R01-CA141661) and from the NIH and FDA (grant U54HL14712). She also receives grant funding from the Tobacco-Related Funding Information: Disease Research Program and the Truth Initiative. Richard O’Connor receives funding from the NIH and FDA (grants U54CA228110, P01CA217806, P01CA200512, R37CA222002, and R21ES030028).
PY - 2022/2/1
Y1 - 2022/2/1
UR - http://www.scopus.com/inward/record.url?scp=85123814712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123814712&partnerID=8YFLogxK
U2 - 10.2105/AJPH.2021.306610
DO - 10.2105/AJPH.2021.306610
M3 - Letter
C2 - 35080952
AN - SCOPUS:85123814712
SN - 0090-0036
VL - 112
SP - e2-e3
JO - American journal of public health
JF - American journal of public health
IS - 2
ER -